With EcTI treatment, a sustained response against human melanoma cells has been observed by inhibiting FAK, SRC, and PI3K proteins and reducing functions essential for tumor regulation, such as cell proliferation, migration, invasion, and cell adhesion to multiple matrix molecules commonly upregulated in melanoma. Here, PTK2 is linked to melanoma.